Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Connectome | 31 | 2022 | 87 | 5.780 |
Why?
|
| White Matter | 21 | 2021 | 89 | 4.460 |
Why?
|
| Nerve Net | 23 | 2021 | 105 | 4.420 |
Why?
|
| Brain Neoplasms | 21 | 2021 | 288 | 4.220 |
Why?
|
| Neural Pathways | 33 | 2022 | 118 | 2.330 |
Why?
|
| Diffusion Tensor Imaging | 31 | 2021 | 79 | 2.290 |
Why?
|
| Occipital Lobe | 9 | 2021 | 21 | 2.140 |
Why?
|
| Neurosurgical Procedures | 12 | 2020 | 213 | 2.060 |
Why?
|
| Magnetic Resonance Imaging | 34 | 2022 | 801 | 1.970 |
Why?
|
| Glioma | 8 | 2019 | 118 | 1.760 |
Why?
|
| Craniotomy | 11 | 2021 | 61 | 1.630 |
Why?
|
| Temporal Lobe | 6 | 2021 | 31 | 1.430 |
Why?
|
| Frontal Lobe | 7 | 2022 | 42 | 1.360 |
Why?
|
| Deep Brain Stimulation | 3 | 2024 | 7 | 1.250 |
Why?
|
| Humans | 80 | 2024 | 26777 | 1.150 |
Why?
|
| Neuroimaging | 19 | 2018 | 86 | 1.090 |
Why?
|
| Retrospective Studies | 23 | 2024 | 2426 | 1.080 |
Why?
|
| Ventriculoperitoneal Shunt | 2 | 2022 | 26 | 0.940 |
Why?
|
| Postoperative Complications | 8 | 2020 | 605 | 0.940 |
Why?
|
| Hydrocephalus | 2 | 2022 | 51 | 0.910 |
Why?
|
| Motor Cortex | 5 | 2021 | 45 | 0.860 |
Why?
|
| Prefrontal Cortex | 5 | 2021 | 79 | 0.800 |
Why?
|
| Parietal Lobe | 7 | 2021 | 26 | 0.770 |
Why?
|
| Functional Neuroimaging | 2 | 2020 | 23 | 0.760 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2021 | 4 | 0.750 |
Why?
|
| Laser Therapy | 1 | 2020 | 30 | 0.730 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2020 | 4 | 0.730 |
Why?
|
| Functional Laterality | 5 | 2021 | 61 | 0.710 |
Why?
|
| Nerve Fibers | 8 | 2018 | 53 | 0.680 |
Why?
|
| Rest | 1 | 2020 | 93 | 0.670 |
Why?
|
| Astrocytoma | 4 | 2020 | 35 | 0.640 |
Why?
|
| Meningioma | 5 | 2019 | 79 | 0.640 |
Why?
|
| Arterial Pressure | 1 | 2018 | 9 | 0.630 |
Why?
|
| Adult | 26 | 2021 | 7359 | 0.620 |
Why?
|
| Middle Aged | 23 | 2021 | 6796 | 0.620 |
Why?
|
| Aged | 19 | 2020 | 5157 | 0.600 |
Why?
|
| Terminal Care | 1 | 2018 | 43 | 0.590 |
Why?
|
| Male | 33 | 2021 | 12842 | 0.590 |
Why?
|
| Gyrus Cinguli | 5 | 2022 | 33 | 0.570 |
Why?
|
| Cauda Equina | 2 | 2016 | 5 | 0.570 |
Why?
|
| Ganglia | 1 | 2016 | 9 | 0.530 |
Why?
|
| Choristoma | 1 | 2016 | 6 | 0.530 |
Why?
|
| Meningeal Neoplasms | 5 | 2019 | 73 | 0.530 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2016 | 17 | 0.530 |
Why?
|
| Low Back Pain | 1 | 2016 | 28 | 0.520 |
Why?
|
| Hypertension | 1 | 2018 | 304 | 0.510 |
Why?
|
| Female | 29 | 2021 | 14421 | 0.490 |
Why?
|
| Seizures | 3 | 2017 | 46 | 0.400 |
Why?
|
| Wakefulness | 4 | 2019 | 23 | 0.390 |
Why?
|
| Follow-Up Studies | 7 | 2019 | 980 | 0.390 |
Why?
|
| Cerebral Cortex | 3 | 2022 | 133 | 0.370 |
Why?
|
| Stereotaxic Techniques | 2 | 2020 | 14 | 0.360 |
Why?
|
| Brain | 4 | 2019 | 696 | 0.360 |
Why?
|
| Brain Mapping | 9 | 2022 | 198 | 0.350 |
Why?
|
| Preoperative Care | 2 | 2020 | 76 | 0.350 |
Why?
|
| Neuronavigation | 2 | 2022 | 9 | 0.340 |
Why?
|
| Cerebrum | 2 | 2019 | 14 | 0.330 |
Why?
|
| Catheters | 2 | 2022 | 23 | 0.330 |
Why?
|
| Attention | 2 | 2019 | 90 | 0.320 |
Why?
|
| Corpus Callosum | 2 | 2019 | 19 | 0.320 |
Why?
|
| Electrodes, Implanted | 3 | 2024 | 40 | 0.310 |
Why?
|
| Treatment Outcome | 8 | 2018 | 2261 | 0.310 |
Why?
|
| Vertebral Artery | 2 | 2018 | 16 | 0.300 |
Why?
|
| Young Adult | 7 | 2020 | 2576 | 0.300 |
Why?
|
| Neoplasms, Neuroepithelial | 2 | 2018 | 9 | 0.290 |
Why?
|
| Electric Power Supplies | 1 | 2024 | 3 | 0.230 |
Why?
|
| Adolescent | 7 | 2019 | 2952 | 0.230 |
Why?
|
| Neoplasm Grading | 3 | 2018 | 104 | 0.220 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2020 | 21 | 0.220 |
Why?
|
| Thalamus | 2 | 2020 | 26 | 0.210 |
Why?
|
| Child | 6 | 2019 | 2141 | 0.210 |
Why?
|
| Basal Ganglia | 2 | 2019 | 9 | 0.210 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 1924 | 0.210 |
Why?
|
| Child, Preschool | 4 | 2019 | 1087 | 0.210 |
Why?
|
| Cadaver | 5 | 2020 | 57 | 0.200 |
Why?
|
| Neurosurgeons | 1 | 2022 | 22 | 0.200 |
Why?
|
| Cerebellar Neoplasms | 2 | 2019 | 28 | 0.200 |
Why?
|
| Skull Fractures | 2 | 2018 | 18 | 0.200 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 2 | 2019 | 9 | 0.200 |
Why?
|
| Semantic Web | 1 | 2021 | 1 | 0.190 |
Why?
|
| Enoxaparin | 1 | 2021 | 36 | 0.190 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2020 | 33 | 0.190 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2020 | 309 | 0.180 |
Why?
|
| Neck Injuries | 2 | 2018 | 6 | 0.180 |
Why?
|
| Auditory Cortex | 1 | 2020 | 1 | 0.180 |
Why?
|
| Apraxias | 1 | 2020 | 2 | 0.180 |
Why?
|
| Electrocorticography | 1 | 2020 | 4 | 0.180 |
Why?
|
| Lasers | 1 | 2020 | 67 | 0.180 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 49 | 0.180 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 98 | 0.180 |
Why?
|
| Eyebrows | 1 | 2020 | 2 | 0.180 |
Why?
|
| Cerebral Peduncle | 1 | 2020 | 3 | 0.180 |
Why?
|
| Movement | 1 | 2021 | 91 | 0.180 |
Why?
|
| Statistics as Topic | 1 | 2020 | 77 | 0.180 |
Why?
|
| Brain Stem Neoplasms | 1 | 2020 | 12 | 0.180 |
Why?
|
| Magnetoencephalography | 1 | 2020 | 26 | 0.180 |
Why?
|
| Carbidopa | 1 | 2019 | 3 | 0.170 |
Why?
|
| Levodopa | 1 | 2019 | 10 | 0.170 |
Why?
|
| Methylphenidate | 1 | 2019 | 7 | 0.170 |
Why?
|
| Suicide, Attempted | 1 | 2019 | 11 | 0.170 |
Why?
|
| Cause of Death | 1 | 2019 | 65 | 0.170 |
Why?
|
| Visual Cortex | 1 | 2019 | 8 | 0.170 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 128 | 0.170 |
Why?
|
| Brain Edema | 1 | 2019 | 22 | 0.170 |
Why?
|
| Hippocampus | 1 | 2021 | 186 | 0.170 |
Why?
|
| Cervical Vertebrae | 2 | 2018 | 111 | 0.170 |
Why?
|
| Cerebral Aqueduct | 1 | 2019 | 4 | 0.170 |
Why?
|
| Inferior Colliculi | 1 | 2019 | 4 | 0.170 |
Why?
|
| Hemangioblastoma | 1 | 2019 | 12 | 0.160 |
Why?
|
| Electroencephalography | 1 | 2020 | 127 | 0.160 |
Why?
|
| Monitoring, Intraoperative | 2 | 2016 | 30 | 0.160 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2019 | 16 | 0.160 |
Why?
|
| Aphasia | 1 | 2019 | 5 | 0.160 |
Why?
|
| Patient Positioning | 1 | 2019 | 22 | 0.160 |
Why?
|
| Sensorimotor Cortex | 1 | 2018 | 7 | 0.160 |
Why?
|
| Anticoagulants | 1 | 2021 | 292 | 0.160 |
Why?
|
| Middle Cerebral Artery | 1 | 2019 | 48 | 0.160 |
Why?
|
| Occipital Bone | 1 | 2018 | 10 | 0.160 |
Why?
|
| Models, Theoretical | 1 | 2019 | 129 | 0.160 |
Why?
|
| Language | 1 | 2019 | 62 | 0.160 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 34 | 0.160 |
Why?
|
| Intracranial Aneurysm | 1 | 2019 | 55 | 0.160 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 116 | 0.160 |
Why?
|
| Radiosurgery | 1 | 2019 | 78 | 0.150 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2018 | 46 | 0.150 |
Why?
|
| Dura Mater | 1 | 2018 | 11 | 0.150 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2018 | 27 | 0.150 |
Why?
|
| Skull Base | 1 | 2018 | 34 | 0.150 |
Why?
|
| Hospitals | 1 | 2018 | 71 | 0.150 |
Why?
|
| Brain Diseases | 1 | 2018 | 35 | 0.150 |
Why?
|
| Psychosurgery | 1 | 2017 | 3 | 0.150 |
Why?
|
| Neurologists | 1 | 2017 | 5 | 0.150 |
Why?
|
| Homosexuality, Male | 1 | 2017 | 15 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 464 | 0.150 |
Why?
|
| Blood Pressure | 1 | 2018 | 351 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 1 | 2019 | 211 | 0.140 |
Why?
|
| Equipment Failure Analysis | 1 | 2017 | 36 | 0.140 |
Why?
|
| Schizophrenia | 1 | 2017 | 45 | 0.140 |
Why?
|
| Abdomen | 1 | 2017 | 41 | 0.140 |
Why?
|
| Glioblastoma | 1 | 2018 | 95 | 0.140 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2017 | 70 | 0.140 |
Why?
|
| Feasibility Studies | 1 | 2017 | 177 | 0.140 |
Why?
|
| Spinal Fractures | 1 | 2017 | 40 | 0.140 |
Why?
|
| Decision Making | 1 | 2018 | 169 | 0.140 |
Why?
|
| Oligodendroglioma | 1 | 2016 | 9 | 0.140 |
Why?
|
| Headache | 1 | 2016 | 30 | 0.140 |
Why?
|
| Cerebral Ventricles | 1 | 2015 | 17 | 0.130 |
Why?
|
| Laminectomy | 1 | 2016 | 30 | 0.130 |
Why?
|
| Arachnoid Cysts | 1 | 2015 | 4 | 0.130 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 20 | 0.130 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2015 | 16 | 0.130 |
Why?
|
| Neural Tube Defects | 1 | 2015 | 19 | 0.130 |
Why?
|
| Ganglioglioma | 1 | 2015 | 4 | 0.130 |
Why?
|
| Dissection | 3 | 2020 | 20 | 0.130 |
Why?
|
| Spinal Cord Diseases | 1 | 2015 | 30 | 0.130 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 122 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 368 | 0.120 |
Why?
|
| United States | 1 | 2019 | 2030 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2018 | 245 | 0.100 |
Why?
|
| Infant | 3 | 2017 | 954 | 0.080 |
Why?
|
| Pyramidal Tracts | 2 | 2017 | 7 | 0.070 |
Why?
|
| Reoperation | 2 | 2017 | 144 | 0.070 |
Why?
|
| Risk Factors | 2 | 2019 | 2009 | 0.050 |
Why?
|
| Speech | 1 | 2021 | 12 | 0.050 |
Why?
|
| Semantics | 1 | 2021 | 11 | 0.050 |
Why?
|
| Models, Anatomic | 1 | 2021 | 25 | 0.050 |
Why?
|
| Hand | 1 | 2021 | 25 | 0.050 |
Why?
|
| Movement Disorders | 1 | 2020 | 4 | 0.050 |
Why?
|
| Subthalamic Nucleus | 1 | 2020 | 3 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2019 | 50 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 43 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 66 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2019 | 68 | 0.040 |
Why?
|
| Language Disorders | 1 | 2019 | 3 | 0.040 |
Why?
|
| Patient Participation | 1 | 2019 | 52 | 0.040 |
Why?
|
| Autopsy | 1 | 2019 | 23 | 0.040 |
Why?
|
| Cerebellum | 1 | 2019 | 41 | 0.040 |
Why?
|
| Hemangiopericytoma | 1 | 2018 | 3 | 0.040 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2018 | 14 | 0.040 |
Why?
|
| Accidents, Traffic | 1 | 2018 | 27 | 0.040 |
Why?
|
| Microsurgery | 1 | 2018 | 43 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2018 | 108 | 0.040 |
Why?
|
| Syndrome | 1 | 2018 | 78 | 0.040 |
Why?
|
| Titanium | 1 | 2018 | 34 | 0.040 |
Why?
|
| Skull Base Neoplasms | 1 | 2018 | 21 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2019 | 701 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2019 | 213 | 0.040 |
Why?
|
| Brain Stem | 1 | 2017 | 22 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 225 | 0.040 |
Why?
|
| Disease Progression | 1 | 2019 | 450 | 0.040 |
Why?
|
| Equipment Design | 1 | 2018 | 211 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2017 | 83 | 0.040 |
Why?
|
| Angiography | 1 | 2017 | 35 | 0.040 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2017 | 17 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2019 | 857 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 133 | 0.030 |
Why?
|
| Karnofsky Performance Status | 1 | 2016 | 15 | 0.030 |
Why?
|
| World Health Organization | 1 | 2016 | 10 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2016 | 15 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 189 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 407 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 298 | 0.030 |
Why?
|
| PubMed | 1 | 2015 | 8 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2015 | 13 | 0.030 |
Why?
|
| Mental Health | 1 | 2016 | 96 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2017 | 841 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 759 | 0.030 |
Why?
|